[Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
D000328:Adult; D000493:Allopurinol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001553:Benzbromarone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001572:Benzofurans / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D014527:Uric Acid / Q000097:blood* / Q000378:metabolism
D001572:Benzofurans; D004338:Drug Combinations; D014527:Uric Acid; D001553:Benzbromarone; D000493:Allopurinol
Vermindertes Risiko bei der Behandlung von Gicht und Hyperurikämie